Tae-Beom Ahn Selected Research

Tae-Beom Ahn Research Topics

Disease

17	Parkinson Disease (Parkinson's Disease) 04/2024 - 10/2004
4	Parkinsonian Disorders (Parkinsonism) 04/2021 - 09/2008
3	Synucleinopathies 11/2022 - 09/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2008
2	Meningoencephalitis 05/2022 - 01/2022
2	Ataxia (Dyssynergia) 01/2022 - 04/2021
2	Inflammation (Inflammations) 01/2020 - 11/2018
2	Dementia (Dementias) 02/2016 - 05/2011
2	Dyskinesias (Dyskinesia) 01/2016 - 06/2007
2	Gliosis 01/2012 - 05/2004
1	Intestinal Volvulus (Volvulus) 11/2023
1	Movement Disorders (Movement Disorder) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Tremor (Tremors) 01/2022
1	Dystonia (Limb Dystonia) 04/2021
1	Ideomotor Apraxia 04/2021
1	Dysbiosis 01/2020
1	Stomach Neoplasms (Stomach Cancer) 08/2019
1	Atrophy 01/2019
1	Dopa-responsive Dystonia 01/2019
1	Nervous System Diseases (Neurological Disorders) 12/2017
1	Dropped Head Syndrome 05/2016
1	Wounds and Injuries (Trauma) 05/2016
1	Diabetes Mellitus 01/2016
1	Hyperglycemia 01/2016
1	Cognitive Dysfunction 12/2014
1	Posterior Leukoencephalopathy Syndrome 01/2014
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2013
1	Atherosclerotic Plaque (Atheroma) 06/2011
1	Hemorrhage 06/2011
1	Atherosclerosis 06/2011
1	Rupture 06/2011
1	Cerebellar Ataxia (Dysmetria) 09/2008
1	Multiple System Atrophy 09/2008
1	Neuroinflammatory Diseases 04/2008
1	Hyperthermia 05/2006
1	Hepatolenticular Degeneration (Wilson's Disease) 06/2005
1	Chronic Hepatitis (Chronic Active Hepatitis) 04/2005
1	Tic Disorders (Tic Disorder) 05/2004
1	Headache (Headaches) 09/2003
1	Antithrombin III Deficiency 09/2003

Drug/Important Bio-Agent (IBA)

7	alpha-SynucleinIBA 11/2023 - 10/2004
5	SynucleinsIBA 11/2022 - 05/2011
4	Levodopa (L Dopa)FDA LinkGeneric 04/2024 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2017
2	Tryptophan (L-Tryptophan)FDA Link 10/2023 - 12/2017
2	Glial Fibrillary Acidic ProteinIBA 05/2022 - 01/2022
2	Ciliary Neurotrophic Factor (CNTF)IBA 11/2018 - 12/2015
1	Dopa DecarboxylaseIBA 04/2024
1	opicaponeIBA 04/2024
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 04/2024
1	Phenobarbital (Luminal)FDA Link 01/2022
1	AutoantibodiesIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Volatile Fatty AcidsIBA 01/2020
1	4-chlorophenyl methyl sulfide (CPMS)IBA 08/2019
1	Tuberculin (PPD)IBA 08/2019
1	Glutamic Acid (Glutamate)FDA Link 12/2017
1	Tyrosine (L-Tyrosine)FDA Link 12/2017
1	levosulpirideIBA 05/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 02/2016
1	amsonic acid (DAS)IBA 01/2016
1	Ciliary Neurotrophic Factor ReceptorIBA 12/2015
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2015
1	QuercetinIBA 07/2015
1	Cholinergic Agents (Cholinergics)IBA 12/2014
1	Neuroprotective AgentsIBA 12/2013
1	ropinirole (Requip)FDA LinkGeneric 08/2011
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2011
1	rotigotine FDA Link 08/2011
1	LipidsIBA 06/2011
1	Matrix Metalloproteinases (MMPs)IBA 06/2011
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2008
1	entacapone (Comtan)FDA Link 06/2007
1	TransferasesIBA 06/2007
1	lactacystinIBA 05/2006
1	CopperIBA 06/2005
1	Superoxide DismutaseIBA 04/2005
1	Carbon MonoxideIBA 05/2004
1	Dopamine (Intropin)FDA LinkGeneric 05/2004

Therapy/Procedure

2	Therapeutics 04/2024 - 12/2015
1	Activities of Daily Living (ADL) 01/2017
1	Induced Hyperthermia (Thermotherapy) 01/2014
1	Transplantation 01/2012
1	Carotid Endarterectomy 06/2011
1	Emergency Treatment 09/2003